12 results
DRS/A
EX-10.16
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
) as a hazardous substance, hazardous waste, hazardous material, pollutant or contaminant, (b) a petroleum hydrocarbon, including crude oil or any fraction
S-1/A
EX-10.26
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
”, “pollutant”, “contaminant”, “waste”, “irritant”, “corrosive”, “flammable”, “radioactive”, “reactive”, “carcinogenic”, “mutagenic”, “bioaccumulative
S-1
EX-10.16
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
) as a hazardous substance, hazardous waste, hazardous material, pollutant or contaminant, (b) a petroleum hydrocarbon, including crude oil or any fraction
10-K
2020 FY
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Mar 21
Annual report
4:22pm
Technologies product categories include HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents and custom services … % of our Biologics Safety Testing revenue in the year ended December 31, 2020.
Other impurity and contaminant kits. Products in this category include
424B4
zh4ts sgfj08
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS/A
wy8g868dfylu7xabhi
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
1i6fhrj6s8cmk nxckja
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
ljrpff0ohj
29 Oct 20
IPO registration
5:04pm
DRS
3nf08q 7dhs
8 Sep 20
Draft registration statement
12:00am
8-K
EX-2.1
fne onzbit960kbsfrk
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
- Prev
- 1
- Next